PT Suparma Tbk (SPMA.JK)

Indonesia · Materials · IDR

Key financials

ROE: 4.36%; 2025 (actual)
ROA: 3.01%; 2025 (actual)
Gross Margin: 15.85%; 2025 (actual)
Net Margin: 3.88%; 2025 (actual)
Total Assets: IDR 3,661.12B; 2025 (actual)
Net Income: IDR 106.23B; 2025 (actual)
Valuation: IDR 984.08B; 2025 (actual)
Stock Price: IDR 184.62; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	4.36%	4.51%	3.93%	3.56%	3.39%	3.19%
Sector average	6.4%	2.44%	-9.34%	4.77%	8.76%	4.61%
ROA	3.01%	3.08%	2.71%	2.5%	2.42%	2.3%
Sector average	4.81%	5.32%	4.47%	3.87%	3.53%	3.22%
Gross Margin	15.85%	15.85%	15.85%	15.85%

Amounts in IDR (billions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for PT Suparma Tbk? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	IDR 3,661.12B	IDR 3,807.22B	IDR 3,887.14B	IDR 3,961.07B	IDR 4,039.68B	IDR 4,116.58B
Sector average	IDR 8,728.64B	IDR 9,495B	IDR 10,120.28B	IDR 10,703.09B	IDR 11,281.15B	IDR 11,857.6B

Net Income	IDR 106.23B	IDR 114.9B	IDR 104.36B	IDR 98.04B	IDR 96.67B	IDR 94B
Sector average	IDR 683.66B	IDR 717.42B	IDR 685.04B	IDR 658.22B	IDR 641.96B	IDR 626.69B

Valuation	IDR 984.08B	IDR 973.88B	IDR 978.39B	IDR 995.51B	IDR 1,022.73B	IDR 1,061.95B
Sector average	IDR 37,456.44B	IDR 40,168.69B	IDR 42,330.23B	IDR 43,261.81B	IDR 44,010.13B	IDR 45,272.86B

Stock Price	IDR 184.62	IDR 182.7	IDR 183.55	IDR 186.76	IDR 191.87	IDR 199.22
Sector average	IDR 2,912.17	IDR 2,505.95	IDR 2,628.59	IDR 2,670.58	IDR 2,709.24	IDR 2,781.81